Ken Griffin acquired 1.66M Bicara Therapeutics Common Stock shares worth $38.5M. That's 0.02% of their equity portfolio (753rd largest holding). The investor owns 3.03% of the outstanding Bicara Therapeutics Common Stock stock. The first Bicara Therapeutics Common Stock trade was made in Q3 2024. Since then Ken Griffin bought shares three more times and sold shares on two occasions. The stake costed the investor $28.3M, netting the investor a gain of 36% so far.